SelectScience co-founder named top tech leader
Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis
Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis
Canadian biotechnology company STEMCELL Technologies has provided critical support to sequence the coronavirus, accelerating vaccine development
DeNovix Inc. expands its fluorescence quantification range with the introduction of the new DeNovix RNA Assay.
New line aims to provide focused solutions for cell culture workflows
Lightsheet 7 platform is designed to reduce imaging artifacts in optical sections
Dr. Jelle Hendrix, Assistant Professor at the Biomedical Research Institute of Hasselt University in Belgium, was presented with this honor
Watch this on-demand webinar to discover important factors in treatment approaches when confronting antimicrobial resistance
Drying chambers to lend a helping hand
Capturing chemi blot images is tricky, which is why Syngene have redesigned their GeneSys software for G:Box Chemi systems
Olympus cellSens imaging software improves the efficiency of your research with accurate object detection and segmentation
Industry expert in virtual slide scanning and upright microscopes shares an innovative combinatory approach to slide observation
Horizon Discovery has announced a new B cell screening service to support the development of therapeutics for immune system diseases
Test runs on Bio-Rad’s QX200 and QXDx ddPCR systems and aims to provide early detection of COVID-19
Join this webinar on solving the complexities of automating assay workflows
In this SelectScience interview, Dr. Arlene Hirano discusses the advantages of using RNAscope HiPlex assays to explore the mammalian retina
A team of academic clinicians from King’s College London and Guy’s and St Thomas’ NHS Foundation Trust identified the novel method “LAMP”
Studies in China show that the QX200 ddPCR systems can detect low levels of infection in individuals
PCR Biosystems have continued to scale up their operations to ensure the ongoing availability of COVID-19 test reagents
The partnership aims to launch a ready-to-go processing solution that streamlines viral DNA/RNA extraction
The test results are designed to enable differential diagnosis in under 2.5 hours
Recent funding from the BARDA award helped the company accelerate development and validation